Masashi Nomura
masashi-nomura.bsky.social
Masashi Nomura
@masashi-nomura.bsky.social
Physician scientist, Glioma single-cell genomics researcher, Neurosurgeon @Tokyo University, Postdoc in Suva lab @MGH/Broad
Reposted by Masashi Nomura
14/ Big thanks also to the institutions that provided tumor samples @dukepress.bsky.social, @mdanderson.bsky.social, Tokyo University Hospital, Pitié-Salpêtrière Hospital, St. Michael's Hospital, Seoul National University and NORLUX and funders NIH, NCI, Mark Foundation and Sontag Foundation.
May 10, 2025 at 10:57 PM
Reposted by Masashi Nomura
13/ @weizmanninstitute.bsky.social, Mass General Brigham (Cancer Center, Pathology), @broadinstitute.org, @yalepress.bsky.social and University of Miami.
May 10, 2025 at 10:57 PM
Reposted by Masashi Nomura
12/ Big thanks to the PIs that supervised the project @itaytirosh.bsky.social, @suvalab.bsky.social, @roelverhaak.bsky.social, Antonio Iavarone and Anna Lasorella, all collaborators and institutions involved in the CARE consortium >
May 10, 2025 at 10:57 PM
Reposted by Masashi Nomura
4/ And now for the results! Across the cohort the most consistent change at recurrence was reduced malignant cell fraction, with a reciprocal increase in glial and neuronal TME cells. This was observed in ~66% of patients, suggesting increased tumor integration into brain tissue.
May 10, 2025 at 10:57 PM
Reposted by Masashi Nomura
3/ We first leveraged this large cohort to revisit the intra- and inter-tumor heterogeneity in GBM and characterized three multi-layered transcriptional ecosystems. Read more about this study in this great thread by @masashi-nomura.bsky.social

bsky.app/profile/masa...
May 10, 2025 at 10:57 PM
I thank my great mentor/boss @suvalab.bsky.social and outstanding co-PIs @itaytirosh.bsky.social, @roelverhaak.bsky.social, Antonio Iavarone and Anna Lasorella. Also appreciate all collaborators, patients and their families who generously provided the samples.
May 9, 2025 at 10:20 AM
12/ Before that, I would like to say thank wonderful co-first authors/friends, @avishayspitzer.bsky.social, @kevin-johnson.bsky.social and Luciano Garofano.
May 9, 2025 at 10:20 AM
11/ How this architecture evolves during progression from primary to recurrent GBM is addressed in the second paper, that will be introduced by @avishayspitzer.bsky.social in the following threads later.
May 9, 2025 at 10:19 AM
10/ These three layers of heterogeneity are inter-related and partially associated with specific genetic aberrations, thereby defining three stereotypic ecosystems in GBM. This work provides an unparalleled view of the multi-layered transcriptional architecture of GBM.
May 9, 2025 at 10:19 AM
9/ Third, after controlling for the frequencies of cellular states, we find that the remaining variation between GBM samples highlights three baseline gene expression programs which we labeled Neuronal, Glial, and Extracellular Matrix.
May 9, 2025 at 10:18 AM
8/ Second, we describe the diversity of cellular states and their pathway-based functional activities, with an expanded set of malignant cell states, including glial progenitor cell-like, neuronal-like, and cilia-like states that were previously depleted by tumor dissociation
May 9, 2025 at 10:18 AM
7/ First, GBMs can be classified by their broad cellular composition, encompassing malignant, immune, vascular, neuronal, and glial cell types.
May 9, 2025 at 10:17 AM
6/ In the first paper, we intensively analyzed GBM cellular heterogeneity, irrespective of time points. Our analyses reveled three transcriptomic layers that contribute to GBM heterogeneity.
May 9, 2025 at 10:17 AM
5/ We divided the findings derived from this large-scale dataset into two papers.
May 9, 2025 at 10:16 AM
4/ We thank @mdanderson.bsky.social, @dukecancer.bsky.social, @uoft.bsky.social, @pitiesalpetriere.bsky.social, NORLUX Neuro-Oncology laboratory, Seoul National University and @utokyoofficial.bsky.social for providing precious primary and recurrent GBM cohorts.
May 9, 2025 at 10:16 AM
3/ In these studies, we collected 121 longitudinal GBM samples from 6 countries under GBM CARE (Cellular Analysis of Resistance and Evolution) consortium, and profiled them by single-nucleus RNA-seq (total 420 k cells).
May 9, 2025 at 10:15 AM
2/These are the fantastic collaborative effort between Suva, Tirosh, Verhaak and Iavarone/Lasorella labs. We appreciate all supports from Mass General Brigham (Cancer Center, Pathology), @broadinstitute.org, Weizmann Institute of Science, @yalepress.bsky.social and University of Miami.
May 9, 2025 at 10:15 AM